State Street Corp Anavex Life Sciences Corp. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, State Street Corp holds 2,411,929 shares of AVXL stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,411,929
Previous 3,065,947
21.33%
Holding current value
$19.9 Million
Previous $17.4 Million
48.75%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AVXL
# of Institutions
188Shares Held
29.2MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$52.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$38.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$15.5 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$9.38 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$7.55 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $645M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...